• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.05% Nasdaq Down0.18%

    Progenics Pharmaceuticals, Inc. (PGNX)

    -NasdaqGS
    5.00 Down 0.19(3.66%) 4:00PM EDT
    |After Hours : 5.00 Down 0.00 (0.02%) 4:42PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue 8,676   44,377   7,862  
    Cost of Revenue -   -   -  
    Gross Profit 8,676   44,377   7,862  
    Operating Expenses
    Research Development28,196  28,592  34,582  
    Selling General and Administrative19,784  9,739  15,341  
    Non Recurring -  2,676  919  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (39,304) 3,370   (42,980)
    Income from Continuing Operations
    Total Other Income/Expenses Net52  51  46  
    Earnings Before Interest And Taxes(39,252)3,421  (42,934)
    Interest Expense -   -   -  
    Income Before Tax(39,252)3,421  (42,934)
    Income Tax Expense(133)(989)(362)
    Minority Interest7   -   -  
    Net Income From Continuing Ops(39,112)4,410  (42,572)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (39,112) 4,410   (42,572)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (39,112) 4,410   (42,572)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.